In vitro antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta
- PMID: 22709723
- PMCID: PMC3473295
- DOI: 10.1186/1476-0711-11-16
In vitro antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta
Abstract
Background: Following claims that some plants have antimicrobial activities against infectious microbes, the in vitro antimicrobial activities of different solvent fractions of ethanolic extract of Cryptolepis sanguinolenta were evaluated against eight standard bacteria and clinical isolates.
Methods: The solvent partitioning protocol involving ethanol, petroleum ether, chloroform, ethyl acetate and water, was used to extract various fractions of dried pulverized Cryptolepis sanguinolenta roots. Qualitative phyto-constituents screening was performed on the ethanol extract, chloroform fraction and the water fraction. The Kirby Bauer disk diffusion method was employed to ascertain the antibiogram of the test organisms while the agar diffusion method was used to investigate the antimicrobial properties of the crude plant extracts. The microplate dilution method aided in finding the MICs while the MBCs were obtained by the method of Nester and friends. The SPSS 16.0 version was used to analyze the percentages of inhibitions and bactericidal activities.
Results: The phytochemical screening revealed the presence of alkaloids, reducing sugars, polyuronides, anthocyanosides and triterpenes. The ethanol extract inhibited 5 out of 8 (62.5%) of the standard organisms and 6 out of 8 (75%) clinical isolates. The petroleum ether fraction inhibited 4 out of 8 (50%) of the standard microbes and 1 out of 8 (12.5%) clinical isolates. It was also observed that the chloroform fraction inhibited the growth of all the organisms (100%). Average inhibition zones of 14.0 ± 1.0 mm to 24.67 ± 0.58 mm was seen in the ethyl acetate fraction which halted the growth of 3 (37.5%) of the standard organisms. Inhibition of 7 (87.5%) of standard strains and 6 (75%) of clinical isolates were observed in the water fraction. The chloroform fraction exhibited bactericidal activity against all the test organisms while the remaining fractions showed varying degrees of bacteriostatic activity.
Conclusion: The study confirmed that fractions of Cryptolepis sanguinolenta have antimicrobial activity. The chloroform fraction had the highest activity, followed by water, ethanol, petroleum ether and ethyl acetate respectively. Only the chloroform fraction exhibited bactericidal activity and further investigations are needed to ascertain its safety and prospects of drug development.
Figures
Similar articles
-
Phytochemical and Pharmacological Review of Cryptolepis sanguinolenta (Lindl.) Schlechter.Adv Pharmacol Sci. 2017;2017:3026370. doi: 10.1155/2017/3026370. Epub 2017 Oct 15. Adv Pharmacol Sci. 2017. PMID: 29750083 Free PMC article. Review.
-
Antimicrobial, antioxidant activities, and total phenolic contents of Pycnanthus angolensis Sap and Cryptolepis sanguinolenta root extracts.BMC Complement Med Ther. 2023 Jun 21;23(1):205. doi: 10.1186/s12906-023-04006-8. BMC Complement Med Ther. 2023. PMID: 37344802 Free PMC article.
-
Antibacterial and anti-inflammatory activities of extract and fractions from Pyrrosia petiolosa (Christ et Bar.) Ching.J Ethnopharmacol. 2014 Sep 11;155(2):1300-5. doi: 10.1016/j.jep.2014.07.029. Epub 2014 Jul 28. J Ethnopharmacol. 2014. PMID: 25077464
-
Anti-bacterial studies on Hemigraphis colorata (Blume) H.G. Hallier and Elephantopus scaber L.Asian Pac J Trop Med. 2012 Jan;5(1):52-7. doi: 10.1016/S1995-7645(11)60245-9. Asian Pac J Trop Med. 2012. PMID: 22182644
-
A review of the anticancer potential of the antimalarial herbal cryptolepis sanguinolenta and its major alkaloid cryptolepine.Ghana Med J. 2013 Sep;47(3):137-47. Ghana Med J. 2013. PMID: 24391229 Free PMC article. Review.
Cited by
-
Evaluation of Natural and Botanical Medicines for Activity Against Growing and Non-growing Forms of B. burgdorferi.Front Med (Lausanne). 2020 Feb 21;7:6. doi: 10.3389/fmed.2020.00006. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32154254 Free PMC article.
-
Phytochemical and Pharmacological Review of Cryptolepis sanguinolenta (Lindl.) Schlechter.Adv Pharmacol Sci. 2017;2017:3026370. doi: 10.1155/2017/3026370. Epub 2017 Oct 15. Adv Pharmacol Sci. 2017. PMID: 29750083 Free PMC article. Review.
-
A Review of the Toxicity and Phytochemistry of Medicinal Plant Species Used by Herbalists in Treating People Living With HIV/AIDS in Uganda.Front Pharmacol. 2021 Apr 15;12:615147. doi: 10.3389/fphar.2021.615147. eCollection 2021. Front Pharmacol. 2021. PMID: 33935707 Free PMC article. Review.
-
The Use of Natural Bioactive Nutraceuticals in the Management of Tick-Borne Illnesses.Microorganisms. 2023 Jul 5;11(7):1759. doi: 10.3390/microorganisms11071759. Microorganisms. 2023. PMID: 37512931 Free PMC article. Review.
-
Antimicrobial, antioxidant activities, and total phenolic contents of Pycnanthus angolensis Sap and Cryptolepis sanguinolenta root extracts.BMC Complement Med Ther. 2023 Jun 21;23(1):205. doi: 10.1186/s12906-023-04006-8. BMC Complement Med Ther. 2023. PMID: 37344802 Free PMC article.
References
-
- Iwu MM. The Handbook of African Medicinal Plants. CRC Press, 200 N. W. Corporate, USA; 1993. pp. 221–222.
-
- Addy M. Cryptolepis: An African traditional medicine that provides hope for malaria victims. HerbalGram. 2003;60:54–59.
-
- Paulo A, Houghton PJ. Chemotaxonomic analysis of the genus Cryptolepis. Biochem Syst Ecol. 2003;31:155–166. doi: 10.1016/S0305-1978(02)00075-3. - DOI
-
- Boye LG, Oku-Ampofo O. Medicinal plants in Ghana. Economic and Medicinal Plant research. Plants Traditional Med. 1990;4:32–33.
-
- Bierer DE, Fort DM, Mendez CD, Luo J, Imbach PA, Dubenko LG, Jolad SD, Gerber RE, Litvak J, Lu Q, Zhang P, Reed MJ, Waldeck N, Bruening RC, Noames BK, Hector RF, Carlson TJ, King SR. Ethnobotanical-directed discovery of the antihyperglycaemic properties of cryptolepine: Its isolation from Cryptolepis sanguinolenta, synthesis and in vitro and in vivo activities. J Med Chem. 1998;41:894–901. doi: 10.1021/jm9704816. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases